Magali Waelbroeck

Magali Waelbroeck publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Magali Waelbroeck sits on this spectrum.

Magali Waelbroeck D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Magali Waelbroeck sits on this spectrum.

Overview

Best Publications

• Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites

  Carine De Vriese;Francoise Gregoire;Roger Lema-Kisoka;Magali Waelbroeck

  357
  Citations

• Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain

  Magali Waelbroeck;Michèle Tastenoy;Jean Claude Camus;Jean Christophe

  348
  Citations

• Development of high affinity selective VIP1 receptor agonists

  Philippe Gourlet;Andre Vandermeers;Pascale Vertongen;Jean Rathe

  271
  Citations

• In vitro properties of a high affinity selective antagonist of the VIP1 receptor

  Philippe Gourlet;Philippe de Neef;Johnny Cnudde;Magali Waelbroeck

  250
  Citations

• Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.

  M. Svoboda;M. Tastenoy;J. Vanrampelbergh;J.F. Goossens

  235
  Citations

• Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.

  Magali Waelbroeck;Patrick Robberecht;David H. Coy;Jean-Claude Camus

  218
  Citations

• The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

  Philippe Gourlet;Pascale Vertongen;Andre Vandermeers;Marie-Claire Vandermeers-piret

  213
  Citations

• Techniques: Promiscuous Gα proteins in basic research and drug discovery

  Evi Kostenis;Magali Waelbroeck;Graeme Milligan

  190
  Citations

• Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes

  Günter Lambrecht;Roland Feifel;Monika Wagner-Röder;Carsten Strohmann

  138
  Citations

• Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes

  Patrick Robberecht;Pierre Chatelain;Philippe De Neef;Jean Claude Camus

  123
  Citations

• Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.

  Magali Waelbroeck;Patrick Robberecht;Pierre Chatelain;Jean Christophe

  120
  Citations

• Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC2 receptor

  D. Moreno;P. Gourlet;P. De Neef;J. Cnudde

  113
  Citations

• The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors

  Philippe Gourlet;Jean-Pierre Vilardaga;Philippe De Neef;Magali Waelbroeck

  110
  Citations

• Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.

  Patrick Robberecht;David H. Coy;Magali Waelbroeck;Mark L. Heiman

  110
  Citations

• Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.

  J.P. Vilardaga;P. Deneef;E. Dipaolo;A. Bollen

  106
  Citations

• Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology

  Jean Christophe;Magali Waelbroeck;Pierre Chatelain;Patrick Robberecht

  105
  Citations

• Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom.

  André Vandermeers;Marie Claire Vandermeers-Piret;Patrick Robberecht;Magali Waelbroeck

  101
  Citations

• Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.

  Magali Waelbroeck;Michel Gillard;Patrick Robberecht;Jean Christophe

  98
  Citations

• The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.

  Jean Van Rampelbergh;Piotr Poloczek;Isabelle Françoys;Christine Delporte

  98
  Citations

• The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors.

  P Robberecht;M Delhaye;G Taton;P De Neef

  92
  Citations